Looking ahead to 2030, our model projects NTLA could trade at an average price of $81.76, with a potential range between $61.32 and $102.20. This represents a potential 475.4% return from today's ...

Intellia Therapeutics (NTLA) recently reported positive topline results from its global Phase 3 HAELO trial of lonvoguran ziclumeran, or lonvo z, for hereditary angioedema, and has started a rolling ...

And it will still have plenty of upside thereafter.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Demand for AI and Nvidia's industry-leading position could drive its stock price significantly higher over the next couple of ...

Intellia Therapeutics, Inc. (NTLA) is expected to deliver a year-over-year increase in earnings on lower revenues when it ...

Here are Cathie Wood’s latest moves.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...

Looking ahead to 2030, our model projects MSFT could trade at an average price of $718.08, with a potential range between $538.56 and $897.60. This represents a potential 76.1% return from today's ...

Primetime Emmys Predictions Commentary All Categories (Updated: May 8, 2026): Get all your paperwork in! Friday, May 8, is the day the Emmy race goes from theoretical to mathematical. Primetime Emmy ...

The quest for Lord Stanley's Cup is down to seven teams, with Round 2 series reaching their climax. The battle is on for what's often said to be the hardest trophy to win in professional sports, but ...